The largest database of trusted experimental protocols

Magmax cell free total nucleic acid isolation kit

Manufactured by Thermo Fisher Scientific
Sourced in United States

The MagMAX Cell-Free Total Nucleic Acid Isolation Kit is a laboratory equipment product designed for the isolation and purification of total nucleic acids, including DNA and RNA, from cell-free samples such as plasma, serum, and other body fluids. The kit utilizes magnetic bead-based technology to capture and purify the nucleic acids, providing a reliable and efficient method for sample preparation.

Automatically generated - may contain errors

17 protocols using magmax cell free total nucleic acid isolation kit

1

Plasma-derived Cell-free Nucleic Acid Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood was collected into 10.0 mL BD Vacutainer® plastic tubes containing EDTA (BD Diagnostics, Milan, Italy). The plasma fraction was obtained and stored as previously described within 2 h of the blood drawing [19 (link)]. Circulating cell-free total nucleic acid (cfTNA) was extracted from 4 mL of plasma with the MagMAX Cell-Free Total Nucleic Acid Isolation Kit (ThermoFisher Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. The circulating cell-free DNA (cfDNA) quantity was estimated using the Qubit 2.0 Fluorometer (Invitrogen, Waltham, MA, USA).
+ Open protocol
+ Expand
2

Saliva and Plasma Nucleic Acid Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Saliva samples were collected as oral rinses. Patients were asked to swish 10 mL of 0.9% sodium chloride in their mouths for 10 to 15 s before spitting into the collection tube. Venous blood (4–10 mL) was collected using standard phlebotomy techniques in EDTA tubes and maintained at 4 °C until further processing. Plasma was obtained from blood within 4 h of phlebotomy upon two sequential centrifugations: the first at 1200× g for 7 min at 4 °C and the second at 14,000× g for 10 min at 4 °C. In some instances, the buffy coat layer was recovered during blood processing, lysed using a BD FACS Lysing Solution (Thermo Fisher Scientific, Waltham, MA, USA), centrifuged at 3000 rpm for 10 min, and stored at −80 °C. The saliva genomic DNA (gDNA) was extracted from 400 μL of oral rinses using a MagMAX Saliva gDNA Isolation Kit (Thermo Fisher Scientific, Waltham, MA, USA). Plasma-circulating cell-free DNA (cfDNA) was extracted from 4 mL of plasma using a MagMAX Cell-Free Total Nucleic Acid Isolation Kit (Thermo Fisher Scientific, Waltham, MA, USA). Leucocyte DNA was extracted using a DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany). DNA was quantified using Qubit Fluorometric Quantification (Thermo Fisher Scientific, Waltham, MA, USA).
+ Open protocol
+ Expand
3

Plasma cfDNA Extraction and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood (1–10 ml) was collected in EDTA tubes and processed within a median of 1 h and 30 min by centrifugation at 2000 × g for 10 min to separate plasma and a buffy coat. The supernatant was removed, and a second centrifugation step was performed at 16,000 × g for 10 min to remove cell debris. All centrifugation steps were performed at 4 °C. The plasma was frozen until DNA isolation. cfDNA was extracted from 500 ul to 9 ml (median 3 ml) plasma samples using the MagMAX™ Cell-Free Total Nucleic Acid Isolation Kit according to the manufacturer’s instructions (Thermo Fisher Scientific, Waltham, MA). The abundance and quality of cfDNA in the extracted samples were assessed using a bioanalyzer Cell-free DNA ScreenTape analysis (Agilent, Santa Clara, CA) and Quantus™ Fluorometer (Promega, Madison, WI).
+ Open protocol
+ Expand
4

cfDNA Extraction and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples (10 mL) were collected from each patient and placed into cfDNA BCT blood collection tube (Streck, Neb). The cfDNA was extracted from 4 ml of plasma using MagMAX cell-free Total Nucleic Acid Isolation Kit (ThermoFisher Scientific, Waltham, Mass), according to the manufacturer's instructions. The quality and quantity of cfDNA were verified respectively using the Agilent High Sensitivity DNA Kit (Agilent Technologies, Palo Alto, Calif) on Agilent2100 Bioanalyzer (Agilent Technologies) and Qubit dsDNA HS Assay Kits on Qubit 2.0 fluorometer (Invitrogen, Carlsbad, Calif).
+ Open protocol
+ Expand
5

Circulating Cell-Free DNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples (10 mL) were collected from each patient and placed into a cell-free DNA BCT® blood collection tube (Streck, NE, USA). Plasma was stored at −80 °C until cfDNA extraction. cfDNA was extracted from 4 mL of plasma using MagMAX cell-free Total Nucleic Acid Isolation Kit (ThermoFisher Scientific, Waltham, MA, USA), according to the manufacturer’s instructions. cfDNA quality and quantity were verified respectively, using the Agilent™ High Sensitivity DNA Kit (Agilent Technologies, Palo Alto, CA, USA) on Agilent2100 Bioanalyzer (Agilent Technologies) and Qubit™ dsDNA HS Assay Kits on Qubit 3.0 fluorometer (Invitrogen, Carlsbad, CA, USA).
+ Open protocol
+ Expand
6

Automated Extraction of Cell-Free DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell-free DNA (cfDNA) was extracted with the MagMAX Cell-Free Total Nucleic Acid Isolation Kit on the KingFisher DuoPrime instrument according to the manufacturer’s instructions (Thermo Fisher Scientific, Waltham, MA, USA). Briefly, 1.5 mL to 6 mL of plasma was incubated with Proteinase K and the Lysis/Binding solution, followed by the automated binding/washing, and elution steps. Elution was performed in 22 µL of the provided elution buffer, and the extracted cfDNA was stored at −20 °C.
+ Open protocol
+ Expand
7

Isolation and Characterization of cfTNA and Genomic DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
cfTNA was extracted from 4 to 8 mL of plasma using the MagMAX Cell-Free Total Nucleic Acid Isolation kit (Thermo Fisher Scientific, Waltham, MA, USA) or NextPrep-Mag cfDNA Automated Isolation Kit (PerkinElmer, Waltham, MA, USA) according to the manufacturer’s protocol. Genomic DNA from buffy coat was extracted using the FlexiGene DNA Kit (Qiagen, Venlo, The Netherlands) or chemagic DNA Blood 400 Kit H96 (PerkinElmer, Waltham, MA, USA).
Genomic DNA of tumor tissue (both tumor and normal, if normal buffy coat DNA was absent) was extracted from ten 5 μm slices of formalin-fixed paraffin-embedded (FFPE) slides, which were macrodissected to leave only the tumor tissue, using GeneRead DNA FFPE Kit (Qiagen, Venlo, The Netherlands), according to the manufacturer’s protocol. The extracted cfTNA and genomic DNA were quantified using the Qubit DNA HS Assay Kit and Qubit DNA BR assay kit (Thermo Fisher Scientific, Waltham, MA, USA), respectively. The quality and size of extracted cfTNA were evaluated using the High Sensitivity D5000 ScreenTape (Agilent, Santa Clara, CA, USA), whereas the quality of genomic DNA was evaluated using the Genomic DNA ScreenTape (Agilent, Santa Clara, CA, USA) with TapeStation System (Agilent, Santa Clara, CA, USA).
+ Open protocol
+ Expand
8

CSF Analysis for Pediatric Neurosurgical Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients aged 0–21 years undergoing neurosurgical intervention for tumor resection or treatment of nonmalignant control diagnoses (ex: hydrocephalus, Chiari malformation, etc.) were eligible for this study (Supplemental Table S1). Patients and parents/guardians consented to an Institutional Review Board (IRB) approved study (CHLA-19-00230). For each patient an attempt was made to collect 3–5mL of CSF in sterile specimen tubes. The CSF was centrifuged at 3000 × g for 10 minutes at 4°C to separate the supernatant and CSF pellet (Supplemental Figure S1). Blood was collected in EDTA tubes, centrifuged at 1900 × g for 10 minutes at 4°C, and separated into plasma and buffy coat for further studies. All samples were immediately frozen at −80°C. DNA was extracted from the CSF supernatant using the MagMAX Cell-Free Total Nucleic Acid Isolation Kit (Thermo Fisher, Waltham, MA). CSF findings were compared to available results of chromosomal microarray (CMA; OncoScan or CytoScanHD; Thermo Fisher) or OncoKids® next-generation sequencing panel from the matched primary tumor specimens processed for clinical testing in the Center for Personalized Medicine at Children’s Hospital Los Angeles (CHLA).22 (link)
+ Open protocol
+ Expand
9

Isolation and Quantification of Cell-Free Nucleic Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma samples were collected in EDTA tubes and stored at −80 °C. For the developmental cohort, cell-free DNA (cfDNA) was obtained from collected peripheral blood using the MagMAXTM Cell-Free DNA Isolation kit (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. For the prospective validation cohort, cell-free total nucleic acid (cfTNA) was extracted from blood using the MagMAX™ Cell-Free Total Nucleic Acid Isolation Kit (Thermo Fisher Scientific, MA, USA). The amounts of cfDNA and cfTNA were quantified using the Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific, MA, USA).
+ Open protocol
+ Expand
10

Sequencing FFPE-Derived Genomic DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The genomic DNA was extracted from FFPE by using MagMAX™ Cell‐Free Total Nucleic Acid Isolation Kit (ThermoFisher Scientific). Qubit quantification was performed after DNA extraction. TaqMan™ GUSB gene assay was performed as a proxy determination of the amplifiable FFPE DNA. Deaminated cytosine bases, commonly found in FFPE specimens, were enzymatically removed by treatment with uracil DNA glycosylase (ThermoFisher Scientific).Target sequencing libraries were constructed with Oncomine™ Comprehensive Assay Plus (DNA+RNA) (ThermoFisher Scientific) with a target 517 cancer‐associated gene panel. Then, target sequencing was performed by Ion GeneStudio™ S5 System (ThermoFisher Scientific) following the manufacturer's instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!